Nancy C Lan, PA
Physician Assistant · Santa Clara
- Medicare standing
- 2 flags on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
On the public record
- California licence: Surrendered
- 1 Medical Board action on record
Offices
2 locations · Permanente Medical Group Inc · 10,928 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Nancy C Lan’s office at (408) 851-1000 to ask if they take your plan before you enroll.
California Medical Board record
Licence C18684 · Surrendered
Licence status: Surrendered · since 1957 · University of Texas Medical Branch at Galveston.
Licensee has surrendered his or her license to resolve a disciplinary or licensing action. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
Public record actions
| 1996-04-23 | Board disciplineDiscipline | Surrender of license. · 08 1995046993 |
Drugs they prescribed that Part D paid
$13,613
Pharmacies billed $13,613 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 33% of their Part D prescriptions (121 of 363) in 2024. Above the middle of the specialty; the typical physician assistant clinician is at 1%.
350 generic and 13 brand-name prescriptions · $13,613 in drug cost · 23 antibiotic prescriptions to 23 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Oxycodone | 87 | $849 | $9 |
| Celecoxib | 67 | $566 | $8 |
| Ondansetron Odt | 71 | $459 | $6 |
| Ibuprofen | 12 | $234 | $13 |
| Hydrocodone-Acetaminophen | 13 | $165 | $9 |
See all 7 drugs
| Oxycodone | 87 | $849 | $9 |
| Celecoxib | 67 | $566 | $8 |
| Ondansetron Odt | 71 | $459 | $6 |
| Ibuprofen | 12 | $234 | $13 |
| Hydrocodone-Acetaminophen | 13 | $165 | $9 |
| Famotidine | 19 | $127 | $7 |
| Doxycycline Monohydrate | 13 | $127 | $10 |
Year by year
| 2024 | 363 | 137 | 33% (121) | 4% | $13,613 |
| 2023 | 372 | 148 | 31% (116) | 3% | $7,748 |
| 2022 | 241 | 98 | 30% (72) | None | $3,317 |
| 2021 | 153 | 69 | 40% (61) | None | $3,215 |
| 2020 | 129 | 64 | 45% (58) | None | $2,920 |
| 2019 | 175 | 78 | 39% (68) | None | $4,475 |
| 2018 | 188 | 78 | 40% (75) | 6% | $5,956 |
| 2017 | 204 | 86 | 31% (64) | None | $7,014 |
| 2016 | 247 | 111 | 41% (100) | 10% | $23,738 |
| 2015 | 179 | 87 | 43% (77) | 18% | $8,248 |
| 2014 | 293 | 121 | 41% (120) | 30% | $27,263 |
| 2013 | 152 | 76 | 41% (63) | 38% | $11,338 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Oxycodone | 92 | $824 | $9 |
| Celecoxib | 61 | $594 | $10 |
| Diclofenac | 13 | $551 | $42 |
| Ondansetron Odt | 67 | $414 | $6 |
| Ibuprofen | 25 | $358 | $14 |
| Famotidine | 39 | $267 | $7 |
| Hydrocodone-Acetaminophen | 12 | $106 | $9 |
2022: 6 drugs
| Oxycodone | 56 | $535 | $10 |
| Celecoxib | 42 | $457 | $11 |
| Ondansetron Odt | 42 | $272 | $6 |
| Ibuprofen | 14 | $200 | $14 |
| Famotidine | 24 | $165 | $7 |
| Meloxicam | 11 | $88 | $8 |
2021: 4 drugs
| Celecoxib | 28 | $280 | $10 |
| Oxycodone-Acetaminophen | 24 | $235 | $10 |
| Oxycodone | 21 | $213 | $10 |
| Ondansetron Odt | 31 | $213 | $7 |
2020: 5 drugs
| Oxycodone-Acetaminophen | 36 | $384 | $11 |
| Ibuprofen | 15 | $221 | $15 |
| Celecoxib | 23 | $213 | $9 |
| Ondansetron Odt | 22 | $208 | $9 |
| Hydrocodone-Acetaminophen | 12 | $102 | $9 |
2019: 5 drugs
| Oxycodone-Acetaminophen | 45 | $657 | $15 |
| Ondansetron Odt | 40 | $403 | $10 |
| Celecoxib | 33 | $305 | $9 |
| Ibuprofen | 16 | $217 | $14 |
| Hydrocodone-Acetaminophen | 12 | $80 | $7 |
2018: 3 drugs
| Oxycodone-Acetaminophen | 59 | $1,103 | $19 |
| Celecoxib | 38 | $1,095 | $29 |
| Ondansetron Odt | 38 | $487 | $13 |
2017: 4 drugs
| Oxycodone-Acetaminophen | 50 | $1,363 | $27 |
| Ondansetron Odt | 41 | $1,050 | $26 |
| Celecoxib | 39 | $928 | $24 |
| Warfarin | 13 | $183 | $14 |
2016: 5 drugs
| Oxycodone-Acetaminophen | 56 | $4,013 | $72 |
| Celecoxib | 46 | $2,057 | $45 |
| Hydrocodone-Acetaminophen | 27 | $658 | $24 |
| Ondansetron Odt | 26 | $358 | $14 |
| Amoxicillin | 37 | $288 | $8 |
2015: 5 drugs
| Oxycodone-Acetaminophen | 39 | $3,625 | $93 |
| Celecoxib | 24 | $1,237 | $52 |
| Hydrocodone-Acetaminophen | 25 | $1,029 | $41 |
| Ibuprofen | 15 | $362 | $24 |
| Amoxicillin | 27 | $208 | $8 |
2014: 7 drugs
| Celebrex | 40 | $9,878 | $247 |
| Oxycodone-Acetaminophen | 65 | $6,368 | $98 |
| Enoxaparin | 15 | $3,175 | $212 |
| Lovenox | 30 | $2,531 | $84 |
| Hydrocodone-Acetaminophen | 32 | $541 | $17 |
| Hydromorphone | 13 | $450 | $35 |
| Amoxicillin | 44 | $365 | $8 |
2013: 5 drugs
| Celebrex | 22 | $6,199 | $282 |
| Lovenox | 32 | $2,582 | $81 |
| Oxycodone-Acetaminophen | 36 | $1,095 | $30 |
| Hydrocodone-Acetaminophen | 21 | $319 | $15 |
| Ibuprofen | 17 | $265 | $16 |
Money from drug and device companies
$18 in 2025
A payment is not proof that care is biased.
| Rigel Pharmaceuticals | Tavalisse | $18 | 1 payment
|
See the published payment
| Rigel Pharmaceuticals | Meals · 2025-11-25 | Tavalisse | $18 |
Professional record
- NPI
- 1790835825
- Licence
- CA 18684California C18684: Surrendered
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant, surgical (363AS0400X)
- Mailing address
- 710 Lawrence Expy, Dept 148, Santa Clara, CA, 95051
- NPI first listed
- 2007-01-11
- NPI last updated
- 2022-01-11
- NPI record certified
- 2022-01-11
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.